CORE -- BIOSTATISTICS /CLINICAL SUPPORT

$210,131P01FY2002NSNIH

University Of Pittsburgh At Pittsburgh, Pittsburgh PA

Investigators

Linked publications & trials

Paper 36497477 Paper 32238439 Paper 29240261 Paper 27889021 Paper 27805285 Paper 27624914 Paper 26984745 Paper 26585571 Paper 26338910 Paper 26044191 Paper 25482928 Paper 25300859 Paper 25200130 Paper 25139025 Paper 24888813 Paper 24741074 Paper 24117271 Paper 24030977 Paper 23740602 Paper 23695963 Paper 23651189 Paper 23609618 Paper 23595625 Paper 23401227 Paper 23376380 Paper 23325792 Paper 23254370 Paper 23152509 Paper 23070115 Paper 23017140 Paper 22753591 Paper 22454247 Paper 22393246 Paper 22282654 Paper 22210182 Paper 22120360 Paper 22086447 Paper 22065046 Paper 21880871 Paper 21806354 Paper 21788981 Paper 21539483 Paper 21382632 Paper 21324923 Paper 21220502 Paper 21149657 Paper 21116835 Paper 20924362 Paper 20861246 Paper 20664932 Paper 20549206 Paper 20508670 Paper 20472682 Paper 20463757 Paper 20463073 Paper 20409732 Paper 20167088 Paper 20144731 Paper 20043719 Paper 19951140 Paper 19913408 Paper 19861464 Paper 19795461 Paper 19783622 Paper 19782703 Paper 19713056 Paper 19622715 Paper 19520829 Paper 19357694 Paper 19348609 Paper 19344302 Paper 19244253 Paper 19242523 Paper 19190335 Paper 19129446 Paper 18973552 Paper 18952584 Paper 18922082 Paper 18841093 Paper 18828174 Paper 18668142 Paper 18579738 Paper 18462865 Paper 18324354 Paper 18321553 Paper 18250414 Paper 18093336 Paper 17900801 Paper 17616706 Paper 17543444 Paper 17295916 Paper 17255279 Paper 16959960 Paper 16618775 Paper 16550610 Paper 16267832 Paper 16263658 Paper 16207473 Paper 16195798 Paper 16081851

Abstract

The Biostatistics, and Clinical Support Core (A) will provide the infrastructure support for the basic and clinical research components of this program. This Biostatistics component of the core will ensure that appropriate statistical parameters are incorporated in the design of the studies of the program, so that in vitro, animal, and patient resources are used efficient, and that rigorous methods are applied for the interpretation and reporting of the results in preclinical and clinical studies. This core will also coordinate the Clinical Support for therapeutic studies conducted within the context of this program by facilitating timely submission of protocols for institutional peer review, maintaining compliance with institutional and federal guidelines, and ensuring that the clinical aspects of this program are integrated seamlessly with the extensive existing resources available within the University of Pittsburgh Cancer Institute.

View original record on NIH RePORTER →